Teva's Biosimilar Boom Just Beginnings: Is It Time to Buy?
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Uncover the rewards credit card that offers the best benefits to enhance your financial experience.
28,009 articlesTeva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Bay Area housing shows a stark split: luxury homes surge on AI-era wealth, while affordable properties slip. Analysts...
UnitedHealth stock quietly soared about 80% off its 2025 low, signaling a meaningful rebound. This article dives into...
A key Senate markup on the CLARITY Act is slated for May 14, with a handful of Democrats deciding whether the bill ad...
Volkswagen signals a smarter-cost strategy to turn around its performance, prioritizing efficiency over plant shutdow...
A startup founded apple vets by former Apple executives has raised $241 million without a single customer, underscori...
Meta quietly positions itself as the strongest mega-cap alternative this summer, leveraging ad momentum and a new AI ...
A three-way push for space-based AI puts Elon Musk and Jeff Bezos in a high-stakes orbit with a rising rival coalitio...
Bahrain’s EDB chief Noor outlines a growth-focused strategy to lure capital despite regional headwinds. bahrain edb’s...
As inflation runs hot and rate prospects swing, retail investors nod to inflation-defensive plays. Smithfield Foods a...
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
AI infrastructure bets push a trillion-dollar spending agenda, yet water-use concerns from almond farming and local o...